PERCEPTIVE ADVISORS LLC

$5.1B reported 13(f) long value · latest quarter 2026-03-31 · CIK 1224962 · EDGAR ↗

sum of disclosed values for 2026-03-31; 0 positions carry a NULL value and are excluded from the sum, surfaced here rather than folded away: $5.1B
ALL retained default holdings for this (filer, period), including NULL-value ones: 94
positions with no comparable holding in the prior quarter (kind new), 2026-03-31: 20
positions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record: 42

A quarter-end snapshot. Filed up to 45 days later, so this page is not current holdings and never a complete portfolio. what a 13F is — and is not ↓ methodology §13F ↗

Position changes — into 2026-03-31

by shares · Δ value · filing link · how changes are classified §

Position changes into quarter 2026-03-31
position matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match `identity_reconciled_by_cusip`	the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE `classified_by_value` · EXIT = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · NO CHANGE = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an ADD or a TRIM (NEW / ADD / TRIM / EXIT / NO CHANGE) · NO PRIOR = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake	derived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero	reported unit changed across the pair (SH↔PRN); the share delta is withheld rather than fabricated `shares_unit_mismatch`	Prev value	Curr value	Prev shares	Curr shares
position key `pos:11142` · issuer key `iss:1475` COM NEW	ADD	+$67.7M	+40,000	$588M	$656M	1,995,986	2,035,986
position key `pos:10390` · issuer key `iss:416` COM	TRIM	+$41.7M	−33,000	$315M	$357M	3,160,200	3,127,200
position key `pos:15965` · issuer key `iss:175` SPONSORED ADR	ADD	+$120M	+450,000	$231M	$350M	1,081,421	1,531,421
position key `pos:17657` · issuer key `iss:2200` SHS	ADD	+$56.2M	+300,000	$173M	$230M	7,985,461	8,285,461
position key `pos:17964` · issuer key `cusip6:152309` SPONSORED ADS	ADD	+$136M	+2,341,269	$73.0M	$209M	2,917,634	5,258,903
position key `pos:16702` · issuer key `iss:1556` COM	TRIM	−$66.1M	−172,596	$273M	$206M	2,546,391	2,373,795
position key `pos:13625` · issuer key `iss:45` COM NEW	ADD	+$90.3M	+714,000	$101M	$191M	3,069,225	3,783,225
position key `pos:13206` · issuer key `iss:1335` COM	TRIM	−$5.6M	−84,600	$167M	$162M	1,665,105	1,580,505
position key `pos:11808` · issuer key `iss:635` COM	TRIM	+$28.7M	−34,000	$111M	$139M	4,457,974	4,423,974
position key `pos:13950` · issuer key `iss:1497` COM	TRIM	+$11.8M	−119,546	$118M	$130M	1,350,425	1,230,879
position key `pos:13239` · issuer key `iss:142` COM	TRIM	−$46.3M	−790,267	$176M	$130M	2,330,651	1,540,384
position key `pos:17702` · issuer key `iss:1818` COM	TRIM	−$40.4M	−135,629	$163M	$123M	4,278,180	4,142,551
position key `pos:12369` · issuer key `iss:1540` COM	ADD	+$80.9M	+7,847,896	$16.1M	$97.0M	1,903,245	9,751,141
position key `pos:15950` · issuer key `iss:970` COM	TRIM	−$17.8M	−10,000	$115M	$97.0M	1,452,707	1,442,707
position key `sid:sec:prov:cc436d9af4067ff4382c62284d4ff9e5` · issuer key `cusip6:98985Y` COM	ADD	+$2.0M	+248,228	$85.9M	$87.9M	3,261,850	3,510,078
position key `pos:11739` · issuer key `iss:1687` COM NEW	ADD	+$19.0M	+73,107	$66.7M	$85.7M	11,833,539	11,906,646
position key `pos:13703` · issuer key `iss:619` COM	ADD	+$16.6M	+1,189,895	$68.0M	$84.6M	3,478,944	4,668,839
position key `pos:15075` · issuer key `iss:265` COM	ADD	+$46.1M	+4,271,504	$24.7M	$70.8M	3,162,529	7,434,033
position key `pos:13812` · issuer key `iss:1378` COM	TRIM	+$23.7M	−81,000	$44.8M	$68.4M	1,476,501	1,395,501
position key `pos:17947` · issuer key `iss:540` COM	TRIM	−$18.6M	−85,000	$78.6M	$60.0M	1,722,290	1,637,290
position key `sid:sec:prov:48ac0f50c981e01f7c5af17d58a117cf` · issuer key `cusip6:67080M` COM	ADD	−$9.9M	+155,000	$67.5M	$57.5M	3,555,877	3,710,877
position key `pos:12487` · issuer key `iss:1240` COM PUT	NEW	+$50.8M	+1,000,000	$0	$50.8M	—	1,000,000
position key `sid:sec:prov:16b2967c1b0bb76b6346bfde109e0bb6` · issuer key `cusip6:23284F` COM	ADD	+$6.2M	+418,639	$41.2M	$47.5M	9,680,185	10,098,824
position key `sid:sec:prov:d8f1dce881f876173d775baaae476159` · issuer key `cusip6:02157Q` COM SHS	ADD	+$13.4M	+225,500	$31.8M	$45.2M	1,784,393	2,009,893
position key `sid:sec:prov:c58e51841f60c26aab31f70d6e4eabc3` · issuer key `cusip6:29286M` COM	TRIM	−$13.3M	−41,570	$53.0M	$39.7M	5,869,076	5,827,506
position key `sid:sec:prov:c0680e314bfe2d1131f5c3d642c67920` · issuer key `cusip6:45258J` COM	TRIM	−$11.0M	−397,507	$50.7M	$39.7M	1,994,890	1,597,383
position key `pos:16805` · issuer key `iss:997` COM NEW	TRIM	−$10.4M	−2,500	$49.8M	$39.4M	87,919	85,419
position key `pos:11517` · issuer key `iss:1003` COM	NEW	+$37.8M	+504,000	$0	$37.8M	—	504,000
position key `sid:sec:prov:5fa73bae4b4007f19790df8489a7fcc7` · issuer key `cusip6:23954D` COM	NEW	+$37.6M	+1,755,799	$0	$37.6M	—	1,755,799
position key `pos:12364` · issuer key `iss:26` SPONSORED ADS	TRIM	−$25.2M	−129,459	$61.8M	$36.6M	458,343	328,884
position key `sid:sec:prov:990effbc09610fc927e1edc54d252d9d` · issuer key `cusip6:221015` COM	ADD	+$28.2M	+1,600,000	$5.3M	$33.5M	692,441	2,292,441
position key `pos:12597` · issuer key `iss:1545` COM	TRIM	−$18.7M	−35,000	$51.7M	$33.1M	315,541	280,541
position key `pos:16214` · issuer key `iss:797` COM NEW	NEW	+$31.7M	+1,223,000	$0	$31.7M	—	1,223,000
position key `sid:sec:prov:19b9675407eb505d5af586b26c66f53a` · issuer key `cusip6:98420X` COM NEW	ADD	+$2.6M	+423,196	$25.3M	$27.8M	6,314,452	6,737,648
position key `pos:17626` · issuer key `iss:860` COM	ADD	+$11.4M	+140,000	$16.3M	$27.7M	160,000	300,000
position key `sid:sec:prov:fed138ced9737b90542a54b9484d2da0` · issuer key `cusip6:10919W` COM NEW	TRIM	−$7.5M	−71,746	$35.1M	$27.5M	449,290	377,544
position key `sid:sec:prov:de0907d604dc0fc94b1a3f8dd009ab9f` · issuer key `cusip6:00534A` COM	TRIM	−$26.7M	−925,863	$53.8M	$27.1M	21,785,166	20,859,303
position key `pos:10212` · issuer key `iss:1665` COM	TRIM	−$22.1M	−520,659	$48.5M	$26.4M	1,179,098	658,439
position key `pos:13067` · issuer key `iss:210` COM	ADD	−$1.9M	+1,050	$27.2M	$25.3M	148,900	149,950
position key `pos:14656` · issuer key `iss:1552` COM	NEW	+$25.1M	+258,600	$0	$25.1M	—	258,600
position key `sid:sec:prov:03d750f8ea50214fdbd147c22363d0f6` · issuer key `cusip6:78397T` COM NEW	ADD	+$21.6M	+5,628,533	$3.0M	$24.6M	803,210	6,431,743
position key `sid:sec:prov:831c753eb8a6ce9972092ec4165601d4` · issuer key `cusip6:07782B` SPONSORED ADS	TRIM	−$42.0M	−262,260	$66.3M	$24.2M	414,239	151,979
position key `sid:sec:prov:9e958f4e10d0d474cc9e75d42ea33a9a` · issuer key `cusip6:88032L` COM NEW	ADD	+$17.8M	+1,008,640	$5.4M	$23.2M	439,142	1,447,782
position key `sid:sec:prov:fd61a14f8c16900d70648b14bc187bfb` · issuer key `cusip6:05463X` COM	TRIM	−$2.6M	−86,828	$25.7M	$23.1M	784,140	697,312
position key `sid:sec:prov:4b145c10f034612809a5ead021971789` · issuer key `cusip6:92790C` COM	TRIM	−$71.8M	−1,871,874	$94.7M	$22.9M	3,042,703	1,170,829
position key `sid:sec:prov:9f123b52d9dfa5657af06135ef52f112` · issuer key `cusip6:68572M` COM	TRIM	+$133K	−89,350	$21.3M	$21.4M	5,127,256	5,037,906
position key `sid:sec:prov:097fe4205cdb81b5acf642533490216f` · issuer key `cusip6:23306J` SPONSORED ADS	NEW	+$20.1M	+964,391	$0	$20.1M	—	964,391
position key `sid:sec:prov:0d957017a1f6113a5600ce99517cee7f` · issuer key `cusip6:03675P` COM	ADD	+$10.7M	+1,750,000	$8.4M	$19.0M	1,675,476	3,425,476
position key `sid:sec:prov:c4149a9e14976bb08df8d6a0cb6dd6b6` · issuer key `cusip6:869367` COM SHS	NEW	+$17.8M	+715,307	$0	$17.8M	—	715,307
position key `pos:11535` · issuer key `iss:1757` COM	ADD	+$12.4M	+295,118	$4.5M	$16.9M	513,035	808,153
position key `sid:sec:prov:05537d56ca21ce3a27a9a933baf06b09` · issuer key `cusip6:21217B` CL A	TRIM	−$342K	−209,000	$16.7M	$16.4M	1,464,592	1,255,592
position key `sid:sec:prov:fefbed769ea5db09695bd4a0f3004463` · issuer key `cusip6:696389` COM	TRIM	−$12.7M	−3,121,851	$28.3M	$15.6M	12,050,000	8,928,149
position key `pos:12344` · issuer key `iss:946` COM	TRIM	−$6.8M	−2,974	$19.2M	$12.4M	108,000	105,026
position key `sid:sec:prov:adbff6ad799c41f5a1fe4cddc6ffc42b` · issuer key `cusip6:30054Y` COM SHS	NEW	+$10.3M	+448,350	$0	$10.3M	—	448,350
position key `sid:sec:prov:7715098c333bbe982e541f4b97bf5506` · issuer key `cusip6:71722W` COM	NEW	+$10.3M	+925,000	$0	$10.3M	—	925,000
position key `sid:sec:prov:87e5cb91aeaa35f0c2f2443d9f9aa785` · issuer key `cusip6:640979` COM	NEW	+$10.0M	+5,104,097	$0	$10.0M	—	5,104,097
position key `sid:sec:prov:748c3ea2043f7dae881221f3c766e002` · issuer key `cusip6:68170A` COM	TRIM	−$27.9M	−1,610,000	$37.8M	$9.9M	2,396,330	786,330
position key `pos:11462` · issuer key `iss:1296` COM	TRIM	−$38.4M	−266,000	$47.0M	$8.6M	331,050	65,050
position key `sid:sec:prov:4e7eb09ab13c64fd6730ede8dbc988b8` · issuer key `cusip6:08659B` COM	ADD	−$9.9M	+240,000	$18.4M	$8.4M	602,944	842,944
position key `sid:sec:prov:bb257ab3c32f69680923bbff7b61bc99` · issuer key `cusip6:67577R` COM	TRIM	−$340K	−2,489,158	$8.7M	$8.4M	4,325,000	1,835,842
position key `pos:18210` · issuer key `iss:263` CL A	ADD	+$1.3M	+19,000	$6.0M	$7.2M	72,812	91,812
position key `pos:17149` · issuer key `iss:1835` COM	NEW	+$7.1M	+150,000	$0	$7.1M	—	150,000
position key `sid:sec:prov:0d3c6673b7060f8873ebd8344c73bee8` · issuer key `cusip6:86889P` COM NEW	NEW	+$6.7M	+229,393	$0	$6.7M	—	229,393
position key `sid:sec:prov:fb9ea7ee3bb27d4ceeeb748915397758` · issuer key `cusip6:00860C` SPONSORED ADS	NEW	+$6.3M	+600,000	$0	$6.3M	—	600,000
position key `sid:sec:prov:3c1bdde45f78766466db92da273259f5` · issuer key `cusip6:30052C` COM	NEW	+$5.3M	+1,286,862	$0	$5.3M	—	1,286,862
position key `sid:sec:prov:26fd673c04b9acd4e799cbdab734d215` · issuer key `cusip6:67576A` COM CALL	NEW	+$4.2M	+500,000	$0	$4.2M	—	500,000
position key `pos:14879` · issuer key `iss:3` COM	TRIM	−$11.9M	−416,235	$16.1M	$4.2M	883,468	467,233
position key `sid:sec:prov:8cb65945c1d745d32abfa3ce25a4d2e9` · issuer key `cusip6:45719W` COM NEW	TRIM	−$7.2M	−3,106,568	$11.1M	$3.9M	5,421,568	2,315,000
position key `pos:16706` · issuer key `iss:2081` COM	TRIM	−$1.6M	−246,744	$5.4M	$3.8M	453,686	206,942
position key `sid:sec:prov:233302be8852a126d4f3dc726082a4c4` · issuer key `cusip6:03753U` COM	NEW	+$3.3M	+80,956	$0	$3.3M	—	80,956
position key `sid:sec:prov:626869004f126eefd6f21e4a4f5ae60f` · issuer key `cusip6:27966L` COM NEW	NEW	+$2.9M	+563,239	$0	$2.9M	—	563,239
position key `pos:15323` · issuer key `iss:37` COM	NEW	+$2.1M	+152,500	$0	$2.1M	—	152,500
position key `pos:16094` · issuer key `iss:512` COM	NEW	+$2.0M	+50,000	$0	$2.0M	—	50,000
position key `sid:sec:prov:72475b3732ae8a64b486fe41b469bb0b` · issuer key `cusip6:696077` COM NEW	TRIM	+$2.5K	−8,055	$1.1M	$1.1M	70,000	61,945
position key `sid:sec:prov:98b422204b4d90393e978b5ebac79307` · issuer key `cusip6:230770` COM	TRIM	−$717K	−144,109	$1.4M	$640K	341,087	196,978
position key `sid:sec:prov:6cea3d644720599797447228551acb50` · issuer key `cusip6:30068X` COM	NEW	+$345K	+114,893	$0	$345K	—	114,893
pos:10141 PUT	EXIT‡e	−$134M	−1,100,000	$134M	$0	1,100,000	—
pos:10385	EXIT‡e	−$34.4M	−110,529	$34.4M	$0	110,529	—
pos:11450	EXIT‡e	−$21.8M	−124,000	$21.8M	$0	124,000	—
pos:11504	EXIT‡e	−$20.5M	−259,545	$20.5M	$0	259,545	—
pos:12161	EXIT‡e	−$35.8M	−450,743	$35.8M	$0	450,743	—
pos:12384	EXIT‡e	−$21.7M	−4,185,632	$21.7M	$0	4,185,632	—
pos:12517	EXIT‡e	−$9.0M	−200,791	$9.0M	$0	200,791	—
pos:12598	EXIT‡e	−$5.4M	−69,935	$5.4M	$0	69,935	—
pos:12631	EXIT‡e	−$20.3M	−237,342	$20.3M	$0	237,342	—
pos:13354	EXIT‡e	−$17.5M	−220,000	$17.5M	$0	220,000	—
pos:13630	EXIT‡e	−$3.6M	−202,400	$3.6M	$0	202,400	—
pos:13686 CALL	EXIT‡e	−$5.6M	−500,000	$5.6M	$0	500,000	—
pos:13935	EXIT‡e	−$4.1M	−165,713	$4.1M	$0	165,713	—
pos:14095	EXIT‡e	−$93.3M	−979,000	$93.3M	$0	979,000	—
pos:14212	EXIT‡e	−$30.7M	−1,136,206	$30.7M	$0	1,136,206	—
pos:14877	EXIT‡e	−$5.4M	−829,870	$5.4M	$0	829,870	—
pos:15034	EXIT‡e	−$15.0M	−225,758	$15.0M	$0	225,758	—
pos:15144	EXIT‡e	−$45.8M	−200,000	$45.8M	$0	200,000	—
pos:15808	EXIT‡e	−$15.8M	−140,000	$15.8M	$0	140,000	—
pos:16881	EXIT‡e	−$4.3M	−17,500	$4.3M	$0	17,500	—
sid:sec:prov:0983c227d7f489fadce1abda0a417532	EXIT‡e	−$28.0M	−825,890	$28.0M	$0	825,890	—
sid:sec:prov:2452fdde4d0b3fb9db6ac52c91059345	EXIT‡e	−$739K	−108,694	$739K	$0	108,694	—
sid:sec:prov:25db868bd92949401541405f5298734d	EXIT‡e	−$9.7M	−550,000	$9.7M	$0	550,000	—
sid:sec:prov:287679ae59495e28d5c5c22eea9bb86e	EXIT‡e	−$4.8M	−747,193	$4.8M	$0	747,193	—

Flags: no row carries a flag.

1–20 of the 100 changes on this page

Mark-to-market only (no share change) · 18

Positions whose share count is identical in both quarters; the value changed with price, not with a decision.

Positions held with no share change into quarter 2026-03-31
position matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match `identity_reconciled_by_cusip`	the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE `classified_by_value` · EXIT = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · NO CHANGE = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an ADD or a TRIM (NEW / ADD / TRIM / EXIT / NO CHANGE) · NO PRIOR = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake	derived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero	Prev value	Curr value	Prev shares	Curr shares
position key `sid:sec:prov:6456a8a739b1b376bb8de72f440b1279` · issuer key `cusip6:03237H` COM	NO CHANGE	+$15.1M	$100M	$115M	8,284,882	8,284,882
position key `sid:sec:prov:8771e17f16590b5bd511978f2a4f7807` · issuer key `cusip6:N44445` SHS	NO CHANGE	−$6.9M	$109M	$102M	10,383,456	10,383,456
position key `sid:sec:prov:8c4f97ba195668adc97a71db173c878f` · issuer key `cusip6:G59665` COM	NO CHANGE	+$7.2M	$82.1M	$89.3M	10,326,103	10,326,103
position key `sid:sec:prov:f31df07e345986c48938525dc4cc3840` · issuer key `cusip6:63909J` COM	NO CHANGE	+$24.3M	$24.6M	$48.9M	12,594,211	12,594,211
position key `pos:14655` · issuer key `iss:2143` SHS USD	NO CHANGE	+$3.2M	$28.9M	$32.1M	170,000	170,000
position key `sid:sec:prov:9fd554b76cc510ac236cd887d1f06195` · issuer key `cusip6:75383L` COM	NO CHANGE	+$640K	$20.4M	$21.1M	673,923	673,923
position key `sid:sec:prov:b4fb61062116268ce297ca59ebf42283` · issuer key `cusip6:04746L` COM	NO CHANGE	+$5.0M	$14.1M	$19.1M	1,859,322	1,859,322
position key `pos:15366` · issuer key `iss:416` NOTE 2.750% 8/0 PRN	NO CHANGE	+$1.8M	$14.1M	$15.9M	6,500,000	6,500,000
position key `sid:sec:prov:d3e1798d38ce2deff0ab7c16a87c8200` · issuer key `cusip6:H5870P` ORDINARY SHARES	NO CHANGE	+$3.3M	$9.9M	$13.1M	493,827	493,827
position key `sid:sec:prov:6298dc09e56171c0480b6cc0aa78c0e3` · issuer key `cusip6:00534B` COM	NO CHANGE	+$741K	$10.3M	$11.0M	9,876,576	9,876,576
position key `pos:17421` · issuer key `iss:475` COM	NO CHANGE	+$360K	$4.3M	$4.7M	121,082	121,082
position key `sid:sec:prov:4dc05f0d17e502f7e6fe21a62e2414d3` · issuer key `cusip6:690145` COM NEW	NO CHANGE	+$108K	$3.1M	$3.2M	833,333	833,333
position key `sid:sec:prov:37b91915f07af95197894a79df85a91e` · issuer key `cusip6:05338F` COM NEW	NO CHANGE	−$451K	$2.5M	$2.1M	139,667	139,667
position key `sid:sec:prov:de9b2d81435d99f71f774196a3faaaf5` · issuer key `cusip6:G23549` SHS	NO CHANGE	−$159K	$2.2M	$2.1M	792,696	792,696
position key `pos:15409` · issuer key `iss:1212` COM CL A	NO CHANGE	+$70.0K	$1.2M	$1.2M	28,000	28,000
position key `pos:13708` · issuer key `iss:1552` *W EXP 12/17/202	NO CHANGE	+$213K	$235K	$448K	250,000	250,000
position key `sid:sec:prov:ea6b923dce62f9f92bb1b29b6ae9b9d1` · issuer key `cusip6:293602` COM NEW	NO CHANGE	−$33.1K	$79.7K	$46.7K	86,666	86,666
position key `sid:sec:prov:c4f97db1890f36f80c7a359d19822318` · issuer key `cusip6:86889P` *W EXP 08/01/203	NO CHANGE	−$666	$3.3K	$2.7K	166,666	166,666

Flags: no row carries a flag.

Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.

Truncated by Public Filings. Changes compare every position with a security identifier, new and exited included; holdings without one are counted, not compared. methodology §13F ↗

Reported positions — 2026-03-31

1–91 of 91 issuers · $5.1B disclosed value over 94 rows · 0 undisclosed-value rows

View

This build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.

This list carries reported issuer names and security identities, without a dated ticker mapping. Symbols are not inferred from names.

a position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filing

Share of total reported value, calculated only when the full position list has disclosed values. This is 13F long value, not total assets.

value undisclosed on the filing: retained and counted, excluded from sums, never shown as $0

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

PRAXIS PRECISION MEDICINES I · COM NEW CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$656M

2,035,986

12.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

CELCUITY INC

2 positions · 2 reported rows

Rows PERCEPTIVE ADVISORS LLC reported for CELCUITY INC, as it reported them
CELCUITY INC · COM CUSIP — src ↗	$357M	3,127,200
CELCUITY INC · NOTE 2.750% 8/0 CUSIP — src ↗	$15.9M	6,500,000 PRN

$373M

—

7.3%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ASCENDIS PHARMA A/S · SPONSORED ADR CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$350M

1,531,421

6.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ROIVANT SCIENCES LTD · SHS CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$230M

8,285,461

4.5%

—

CENTESSA PHARMACEUTICALS PLC · SPONSORED ADS CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$209M

5,258,903

4.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

RHYTHM PHARMACEUTICALS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$206M

2,373,795

4.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

SPYRE THERAPEUTICS INC · COM NEW CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$191M

3,783,225

3.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

NUVALENT INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$162M

1,580,505

3.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

EDGEWISE THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$139M

4,423,974

2.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

PROTAGONIST THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$130M

1,230,879

2.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

APOGEE THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$130M

1,540,384

2.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

TRAVERE THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$123M

4,142,551

2.4%

—

AMYLYX PHARMACEUTICALS INC · COM CUSIP 03237H101
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$115M

8,284,882

2.3%

—

IMMATICS N.V · SHS CUSIP N44445109
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$102M

10,383,456

2.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

RELAY THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$97.0M

9,751,141

1.9%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

INHIBRX BIOSCIENCES INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$97.0M

1,442,707

1.9%

—

MEIRAGTX HLDGS PLC · COM CUSIP G59665102
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$89.3M

10,326,103

1.7%

—

ZYMEWORKS INC · COM CUSIP 98985Y108
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$87.9M

3,510,078

1.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

SOLID BIOSCIENCES INC · COM NEW CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$85.7M

11,906,646

1.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

DYNE THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$84.6M

4,668,839

1.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

BIOCRYST PHARMACEUTICALS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$70.8M

7,434,033

1.4%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ORUKA THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$68.4M

1,395,501

1.3%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ARTIVION INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$60.0M

1,637,290

1.2%

—

NURIX THERAPEUTICS INC · COM CUSIP 67080M103
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$57.5M

3,710,877

1.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

MODERNA INC · COM · PUT CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$50.8M

1,000,000

1.0%

—

NAUTILUS BIOTECHNOLOGY INC · COM CUSIP 63909J108
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$48.9M

12,594,211

1.0%

—

CYTOMX THERAPEUTICS INC. · COM CUSIP 23284F105
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$47.5M

10,098,824

0.9%

—

ALTO NEUROSCIENCE INC · COM SHS CUSIP 02157Q109
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$45.2M

2,009,893

0.9%

—

ENGENE HOLDINGS INC · COM CUSIP 29286M105
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$39.7M

5,827,506

0.8%

—

IMMUNOVANT INC · COM CUSIP 45258J102
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$39.7M

1,597,383

0.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

INTUITIVE SURGICAL INC · COM NEW CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$39.4M

85,419

0.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

IONIS PHARMACEUTICALS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$37.8M

504,000

0.7%

—

DAY ONE BIOPHARMACEUTICALS I · COM CUSIP 23954D109
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$37.6M

1,755,799

0.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ABIVAX SA · SPONSORED ADS CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$36.6M

328,884

0.7%

—

CORVUS PHARMACEUTICALS INC · COM CUSIP 221015100
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$33.5M

2,292,441

0.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

REPLIGEN CORP · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$33.1M

280,541

0.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

JAZZ PHARMACEUTICALS PLC · SHS USD CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$32.1M

170,000

0.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

DAMORA THERAPEUTICS INC · COM NEW CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$31.7M

1,223,000

0.6%

—

X4 PHARMACEUTICALS INC · COM NEW CUSIP 98420X202
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$27.8M

6,737,648

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

GUARDANT HEALTH INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$27.7M

300,000

0.5%

—

BRIGHT MINDS BIOSCIENCES INC · COM NEW CUSIP 10919W405
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$27.5M

377,544

0.5%

—

INVIVYD INC · COM CUSIP 00534A102
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$27.1M

20,859,303

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

SIONNA THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$26.4M

658,439

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

REVOLUTION MEDICINES INC

2 positions · 2 reported rows

Rows PERCEPTIVE ADVISORS LLC reported for REVOLUTION MEDICINES INC, as it reported them
REVOLUTION MEDICINES INC · COM CUSIP — src ↗	$25.1M	258,600
REVOLUTION MEDICINES INC · *W EXP 12/17/202 CUSIP — src ↗	$448K	250,000

$25.6M

508,600

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

AXSOME THERAPEUTICS INC. · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$25.3M

149,950

0.5%

—

SAB BIOTHERAPEUTICS INC · COM NEW CUSIP 78397T202
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$24.6M

6,431,743

0.5%

—

BELITE BIO INC · SPONSORED ADS CUSIP 07782B104
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$24.2M

151,979

0.5%

—

TENAX THERAPEUTICS INC · COM NEW CUSIP 88032L605
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$23.2M

1,447,782

0.5%

—

AXOGEN INC · COM CUSIP 05463X106
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$23.1M

697,312

0.5%

—

VIRIDIAN THERAPEUTICS INC · COM CUSIP 92790C104
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$22.9M

1,170,829

0.4%

—

ORCHESTRA BIOMED HLDGS INC · COM CUSIP 68572M106
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$21.4M

5,037,906

0.4%

—

RAPPORT THERAPEUTICS INC · COM CUSIP 75383L102
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$21.1M

673,923

0.4%

—

DBV TECHNOLOGIES S A · SPONSORED ADS CUSIP 23306J309
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$20.1M

964,391

0.4%

—

LEONABIO INC · COM CUSIP 04746L203
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$19.1M

1,859,322

0.4%

—

ANTERIS TECHNOLOGIES GLOBAL · COM CUSIP 03675P102
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$19.0M

3,425,476

0.4%

—

SUTRO BIOPHARMA INC · COM SHS CUSIP 869367201
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$17.8M

715,307

0.3%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

TANGO THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$16.9M

808,153

0.3%

—

CONTINEUM THERAPEUTICS INC · CL A CUSIP 21217B100
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$16.4M

1,255,592

0.3%

—

PALISADE BIO INC · COM CUSIP 696389402
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$15.6M

8,928,149

0.3%

—

OCULIS HOLDING AG · ORDINARY SHARES CUSIP H5870P102
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$13.1M

493,827

0.3%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

IRHYTHM HOLDINGS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$12.4M

105,026

0.2%

—

ADAGIO MED HLDGS INC · COM CUSIP 00534B100
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$11.0M

9,876,576

0.2%

—

EVOMMUNE INC · COM SHS CUSIP 30054Y107
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$10.3M

448,350

0.2%

—

PHATHOM PHARMACEUTICALS INC · COM CUSIP 71722W107
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$10.3M

925,000

0.2%

—

NEUMORA THERAPEUTICS INC. · COM CUSIP 640979100
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$10.0M

5,104,097

0.2%

—

OMADA HEALTH INC · COM CUSIP 68170A108
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$9.9M

786,330

0.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

NEUROCRINE BIOSCIENCES INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$8.6M

65,050

0.2%

—

BETA BIONICS INC · COM CUSIP 08659B102
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$8.4M

842,944

0.2%

—

OPUS GENETICS INC · COM CUSIP 67577R102
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$8.4M

1,835,842

0.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

BILLIONTOONE INC · CL A CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$7.2M

91,812

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

TWIST BIOSCIENCE CORP · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$7.1M

150,000

0.1%

—

SURROZEN INC

2 positions · 2 reported rows

Rows PERCEPTIVE ADVISORS LLC reported for SURROZEN INC, as it reported them
SURROZEN INC · COM NEW CUSIP 86889P208 src ↗	$6.7M	229,393
SURROZEN INC · *W EXP 08/01/203 CUSIP 86889P117 src ↗	$2.7K	166,666

ticker not yet mapped

$6.7M

396,059

0.1%

—

AGOMAB THERAPEUTICS NV · SPONSORED ADS CUSIP 00860C102
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$6.3M

600,000

0.1%

—

EVOLUS INC · COM CUSIP 30052C107
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$5.3M

1,286,862

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

COGENT BIOSCIENCES INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$4.7M

121,082

0.1%

—

OCULAR THERAPEUTIX INC · COM · CALL CUSIP 67576A100
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$4.2M

500,000

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ADMA BIOLOGICS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$4.2M

467,233

0.1%

—

INHIBIKASE THERAPEUTICS INC · COM NEW CUSIP 45719W205
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$3.9M

2,315,000

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

CRESCENT BIOPHARMA INC. · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$3.8M

206,942

0.1%

—

APELLIS PHARMACEUTICALS INC · COM CUSIP 03753U106
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$3.3M

80,956

0.1%

—

OUTSET MED INC · COM NEW CUSIP 690145206
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$3.2M

833,333

0.1%

—

EDESA BIOTECH INC · COM NEW CUSIP 27966L306
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$2.9M

563,239

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ADAPTIVE BIOTECHNOLOGIES COR · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$2.1M

152,500

0.0%

—

AVALO THERAPEUTICS INC · COM NEW CUSIP 05338F306
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$2.1M

139,667

0.0%

—

CONNECT BIOPHARMA HLDGS LTD · SHS CUSIP G23549101
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$2.1M

792,696

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

CORCEPT THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$2.0M

50,000

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

MEDLINE INC · COM CL A CUSIP —
2026-03-31 filed 2026-05-29 +59d

src ↗

$1.2M

28,000

0.0%

—

PALATIN TECHNOLOGIES INC · COM NEW CUSIP 696077601
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$1.1M

61,945

0.0%

—

CUMBERLAND PHARMACEUTICALS I · COM CUSIP 230770109
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$640K

196,978

0.0%

—

EXAGEN INC · COM CUSIP 30068X103
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$345K

114,893

0.0%

—

ENSYSCE BIOSCIENCES INC · COM NEW CUSIP 293602504
2026-03-31 filed 2026-05-29 +59d

src ↗

ticker not yet mapped

$46.7K

86,666

0.0%

1–20 of 91 issuers

Change kind and share change are in Position changes above; Congress overlap is planned.

One line per issuer, largest first; a row with no issuer key stands on its own line. Open a line for its rows as this filer reported them. The list holds every row this filer reported for the quarter. Issuer totals on the holders pages count each manager's own report once; that never removes a row here. how positions are grouped ↗

Book shape

2026-03-31 · concentration · vs tracked median · tick = median

Top-25 concentration: 77.2%below median 80.0%
Concentration index: 410 bpsbelow median 446 bps
Positions with value: 94 / 94median book 97.5 positions

Concentration uses reported 13F long value, not total assets. The index is withheld when any position lacks a value. Medians are over the 8,748 tracked filers with a 2026-03-31 book; the index median over the 8,662 with a complete book.

holdings whose <value> did not parse — retained and counted, never zero-filled: 0 · share of the period's disclosed value held in the top-N positions; denominator is reported 13F value, not total assets: 77.2% · integer Herfindahl–Hirschman index in basis points over disclosed position values: 410 · QoQ moves: 136

Filing history

AVAILABLE QUARTERS

Available filing periods
Period	Source
2026-03-31	EDGAR ↗

PLANNED sector rotation · Congress overlap · signals for this filer

Complete source filings on SEC EDGAR

The complete filing on EDGAR.

The position list above is served from the published Public Filings build, each position as this filer reported it; where the page cannot embed every reported row, the list says how many it leaves out. This block is provenance, not a substitute: the filing itself is the record, and it is one click away. Public Filings decided on 2026-08-01 to serve this list from its published build; filings newer than this build are on EDGAR.

Open PERCEPTIVE ADVISORS LLC's 13F filings on SEC EDGAR ↗

Notes on this data

Reported positions

Quarter-end holdings as filed

Explore the full published position list and its source filing. This record excludes the manager’s cash, shorts and non-13(f) assets.

Share changes

Compare consecutive quarters

Position changes retain the producer’s classification and comparability flags. Share counts and reported values describe different changes.

Coverage

A snapshot, not current holdings

Use the quarter selector to inspect available periods. Unknown values stay unknown and each table states its coverage.

A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗

13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.

Positions are quarter-end snapshots filed up to 45 days late — not current holdings. A position may have been changed or closed before you ever see it, and is older still by however long ago that quarter ended.

Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars with unit_basis carried on every record.

Affiliated managers may report the same position (otherManager), so one position can appear under more than one filer.

Positions under confidential treatment may be omitted until a later amendment discloses them.

These are disclosures, not investment advice (ARCHITECTURE.md §5.2 / M2-CONTRACT §5).